Diaceutics to present at AICon 2019 - Diaceutics

Diaceutics to present at AICon 2019

Diaceutics PLC (AIM: DXRX), the data analytics and implementation services company which services the global pharmaceutical industry, announces they will be presenting at the inaugural AICon, 2019. AICon will take place on Thursday, 28 November in The Europa Hotel, Belfast.

AICon is a world-class conference for professionals, developers, creatives, entrepreneurs and business leaders who have led on adopting artificial intelligence (AI) as a tool to provide better services, products and businesses. The event focuses on industry leaders currently working within the AI space from multiple industries. The topics of discussion will be primarily on breakthroughs and advantages of AI in current business processes, what the latest technologies are and how they are being applied in the relevant fields.

Wendy Moore, Knowledge & Insights Director and Scott Morrison, Data Science Director at Diaceutics will deliver a joint presentation on using AI/ML to improve patient pathways. They will discuss the challenges of (GDPR/HIPA) and how they effect the visibility of the pathway. As well as this, they will present the projects they are working on in the AI/ML field to give visibility into the patient pathway and the best actions a patient can take to get to an outcome.

A summary of the presentation content will be available on the Diaceutics website from 28 November.


Diaceutics PLC www.diaceutics.com
Peter Keeling, Chief Executive Officer via Walbrook PR
Philip White, Chief Financial Officer via Walbrook PR
Cenkos Securities plc (Nominated adviser and broker) +44 (0) 20 7391 8900
Callum Davidson / Giles Balleny
Michael Johnson (Sales)
Walbrook PR Tel: +44 (0)20 7933 8780 or diaceutics@walbrookpr.com
Anna Dunphy Mob: +44 (0)7876 741 001
Paul McManus Mob: +44 (0)7980 541 893

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialisation of precision medicine diagnostics. The Group, listed on the AIM Market of the London Stock Exchange, has created commercially useful data sets for every precision medicine that has come to market. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.  www.diaceutics.com

Latest Blogs

Latest Blogs